Gary C. Stratmann

1.2k total citations
20 papers, 958 citations indexed

About

Gary C. Stratmann is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Gary C. Stratmann has authored 20 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 9 papers in Cellular and Molecular Neuroscience and 6 papers in Molecular Biology. Recurrent topics in Gary C. Stratmann's work include Alzheimer's disease research and treatments (10 papers), Neuroscience and Neuropharmacology Research (8 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Gary C. Stratmann is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Neuroscience and Neuropharmacology Research (8 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Gary C. Stratmann collaborates with scholars based in United Kingdom, Mexico and United States. Gary C. Stratmann's co-authors include Andrew Procter, David M. Bowen, Alan M. Palmer, Paul T. Francis, D. M. Bowen, Stephen L. Lowe, A.J. Cross, Matthew T. Webster, R.C.A. Pearson and Margaret M. Esiri and has published in prestigious journals such as Annals of Neurology, Brain Research and Annals of the New York Academy of Sciences.

In The Last Decade

Gary C. Stratmann

20 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary C. Stratmann United Kingdom 14 537 327 266 244 232 20 958
J. S. Benton United Kingdom 6 521 1.0× 380 1.2× 354 1.3× 369 1.5× 357 1.5× 7 1.1k
J. A. Spillane United Kingdom 9 524 1.0× 374 1.1× 415 1.6× 379 1.6× 272 1.2× 12 1.1k
Reiji Iizuka Japan 15 409 0.8× 313 1.0× 265 1.0× 148 0.6× 119 0.5× 23 864
Wojciech Danysz Germany 11 495 0.9× 196 0.6× 270 1.0× 189 0.8× 119 0.5× 12 751
Robert Zöchling Germany 9 521 1.0× 448 1.4× 495 1.9× 203 0.8× 174 0.8× 10 1.4k
Peter Davies United States 7 647 1.2× 333 1.0× 560 2.1× 292 1.2× 200 0.9× 8 1.2k
Lakhbir Singh United Kingdom 9 810 1.5× 431 1.3× 501 1.9× 179 0.7× 177 0.8× 9 1.4k
Li‐Jan Chang Canada 12 474 0.9× 399 1.2× 495 1.9× 148 0.6× 131 0.6× 14 1.2k
D Lodge United Kingdom 14 1.1k 2.1× 240 0.7× 811 3.0× 154 0.6× 175 0.8× 26 1.5k
William G. Honer Canada 10 327 0.6× 455 1.4× 240 0.9× 57 0.2× 146 0.6× 15 894

Countries citing papers authored by Gary C. Stratmann

Since Specialization
Citations

This map shows the geographic impact of Gary C. Stratmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary C. Stratmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary C. Stratmann more than expected).

Fields of papers citing papers by Gary C. Stratmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary C. Stratmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary C. Stratmann. The network helps show where Gary C. Stratmann may publish in the future.

Co-authorship network of co-authors of Gary C. Stratmann

This figure shows the co-authorship network connecting the top 25 collaborators of Gary C. Stratmann. A scholar is included among the top collaborators of Gary C. Stratmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary C. Stratmann. Gary C. Stratmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Francis, Paul T., et al.. (1995). Cholinomimetics Increase Glutamate Outflow via an Action on the Corticostriatal Pathway: Implications for Alzheimer's Disease. Journal of Neurochemistry. 65(5). 2165–2169. 37 indexed citations
2.
Francis, Paul T., et al.. (1995). NMDA‐induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5‐HT1A antagonist. British Journal of Pharmacology. 115(7). 1169–1174. 60 indexed citations
3.
Procter, Andrew, Paul T. Francis, Chris Holmes, et al.. (1994). ?-Amyloid precursor protein isoforms show correlations with neurones but not with glia of demented subjects. Acta Neuropathologica. 88(6). 545–552. 9 indexed citations
4.
Stratmann, Gary C., Matthew T. Webster, Paul T. Francis, Andrew Procter, & D. M. Bowen. (1994). Brain Membrane Serine Protease Activity in Human Cortex Compared with Rat: Implication for Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders. 5(2). 62–68. 11 indexed citations
5.
Webster, Matthew T., Paul T. Francis, Andrew Procter, et al.. (1994). Postmortem brains reveal similar but not identical amyloid precursor protein-like immunoreactivity in Alzheimer compared with other dementias. Brain Research. 644(2). 347–351. 10 indexed citations
6.
Francis, Paul T., Courtney Holmes, Matthew T. Webster, et al.. (1993). Preliminary Neurochemical Findings in Non-Alzheimer Dementia due to Lobar Atrophy. Dementia and Geriatric Cognitive Disorders. 4(3-4). 172–177. 56 indexed citations
7.
Rauh, G, H. Schuster, Gary C. Stratmann, et al.. (1993). Independent mutation of arginine(3500)→glutamine associated with familial defective apolipoprotein B-100. Journal of Lipid Research. 34(5). 799–805. 20 indexed citations
8.
Francis, Paul T., Iain P. Chessell, Chris Holmes, et al.. (1993). Neurotransmitters and Second Messengers in Aging and Alzheimer's Disease. Annals of the New York Academy of Sciences. 695(1). 19–26. 22 indexed citations
9.
Procter, Andrew, Paul T. Francis, Gary C. Stratmann, & David M. Bowen. (1992). Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms. Neurochemical Research. 17(9). 917–922. 57 indexed citations
10.
Francis, Paul T., Menelas N. Pangalos, R.C.A. Pearson, et al.. (1992). 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin.. Journal of Pharmacology and Experimental Therapeutics. 261(3). 1273–1281. 66 indexed citations
11.
Procter, Andrew, Gary C. Stratmann, Paul T. Francis, et al.. (1991). Characterisation of the Glycine Modulatory Site of the N‐Methyl‐d‐Aspartate Receptor‐Ionophore Complex in Human Brain. Journal of Neurochemistry. 56(1). 299–310. 28 indexed citations
12.
Schuster, H., Sabine Richter, Gary C. Stratmann, et al.. (1991). Identification of a silent point mutation in the LDL-receptor gene by direct DNA sequencing. Journal of Molecular Medicine. 69(12). 517–521. 7 indexed citations
13.
Procter, Andrew, et al.. (1989). Reduced Glycine Stimulation of [3H]MK‐801 Binding in Alzheimer's Disease. Journal of Neurochemistry. 53(3). 698–704. 97 indexed citations
14.
Procter, Andrew, et al.. (1989). Loss of glycine-dependent radioligand binding to the receptor complex in patients with Alzheimer's disease. Neuroscience Letters. 101(1). 62–66. 52 indexed citations
15.
Steele, Janet, Alan M. Palmer, Gary C. Stratmann, & David M. Bowen. (1989). The N-methyl-d-aspartate receptor complex in Alzheimer's disease: reduced regulation by glycine but not zinc. Brain Research. 500(1-2). 369–373. 36 indexed citations
16.
Procter, Andrew, Stephen L. Lowe, Alan M. Palmer, et al.. (1988). Topographical distribution of neurochemical changes in Alzheimer's disease. Journal of the Neurological Sciences. 84(2-3). 125–140. 113 indexed citations
17.
Palmer, Alan M., Gary C. Stratmann, Andrew Procter, & David M. Bowen. (1988). Possible neurotransmitter basis of behavioral changes in alzheimer's disease. Annals of Neurology. 23(6). 616–620. 168 indexed citations
18.
Brown, J M, et al.. (1987). The Variability and Dietary Dependence of Urinary Oxalate Excretion in Recurrent Calcium Stone Formers. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 24(4). 385–390. 7 indexed citations
19.
Francis, Paul T., Stephen L. Lowe, Alan M. Palmer, et al.. (1986). Excitatory amino acid neurotransmitters, somatostatin and degenerate cortical neurons in Alzheimer's disease. Biochemical Society Transactions. 14(5). 911–912. 2 indexed citations
20.
Palmer, Alan M., Andrew Procter, Gary C. Stratmann, & David M. Bowen. (1986). Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease. Neuroscience Letters. 66(2). 199–204. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026